FDA Inspection
Actavis Elizabeth LLC, A Company of TevaActavis Elizabeth LLC, A Company of Teva – FDA Inspection, May 19, 2017
Record Details
This FDA Inspection record concerns Actavis Elizabeth LLC, A Company of Teva, with an inspection on May 19, 2017, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · dffeb558-428a-4b1e-b4e2-3dcc7d29cb77
Inspection Facts
- Inspection number
- 1017122
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Actavis Elizabeth LLC, A Company of Teva
14| Date | Classification | Office | Project area |
|---|---|---|---|
| July 24, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 15, 2017 | NAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| December 5, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 27, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Actavis Elizabeth LLC, A Company of Teva
- FDA Inspection 1215838 - 2023-07-24
- FDA Inspection 1041770 - 2018-02-05
- FDA Inspection 1003801 - 2017-02-15
- FDA Inspection 994679 - 2016-12-05
- FDA Inspection 939866 - 2015-08-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.